![David D. Elks](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in David D. Elks first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 19 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to David D. Elks via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | General Counsel | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Pharmaceutical Product Development LLC
![]() Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Miscellaneous Commercial Services | Chief Executive Officer | |
Shire ViroPharma, Inc.
![]() Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Investor Relations Contact | |
FENNEC PHARMACEUTICALS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
ACORDA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
ZYNERBA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
University of Virginia | College/University | Undergraduate Degree | |
GSK PLC | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
GW PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
Wake Forest University | College/University | Doctorate Degree | |
San Diego State University | College/University | Graduate Degree | |
Case Western Reserve University
![]() Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Doctorate Degree Doctorate Degree | |
George Mason University | College/University | Masters Business Admin | |
Indiana University | College/University | Masters Business Admin Undergraduate Degree | |
Lehigh University | College/University | Graduate Degree | |
University of Michigan | College/University | Undergraduate Degree | |
University of New Hampshire | College/University | Undergraduate Degree | |
The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
University of San Francisco | College/University | Undergraduate Degree | |
Washington & Lee University | College/University | Undergraduate Degree | |
Western Carolina University | College/University | Undergraduate Degree | |
ENDOCYTE, INC. | Pharmaceuticals: Major | General Counsel | |
Astellas Pharma US, Inc.
![]() Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Pharmaceuticals: Major | Corporate Officer/Principal | |
UCB Pharma, Inc.
![]() UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The North Carolina Biotechnology Center
![]() The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Internet Software/Services | Director/Board Member Director/Board Member | |
VERONA PHARMA PLC | Pharmaceuticals: Major | Human Resources Officer | |
Pharmaceutical Research & Manufacturers of America
![]() Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Coleman Research, Inc. | Human Resources Officer | ||
KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
GlaxoSmithKline LLC
![]() GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Keller Graduate School of Management | College/University | Masters Business Admin | |
The University of North Carolina at Charlotte | College/University | Undergraduate Degree | |
Orchard Therapeutics (Europe) Ltd.
![]() Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Human Resources Officer | |
Istari Oncology, Inc.
![]() Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Rutgers University-New Brunswick | College/University | Masters Business Admin | |
ERASCA, INC. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
Abdera Therapeutics, Inc.
![]() Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Biotechnology | Chairman | |
Incyclix Bio LLC
![]() Incyclix Bio LLC Pharmaceuticals: MajorHealth Technology Incyclix Bio, Inc., formerly known as Arc Therapeutics, is a pharmaceutical company that focuses on developing small molecule inhibitors of cyclin-dependent kinases (CDKs) to treat advanced and resistant cancers. The company is based in Durham, NC. The company's team has unique insights into the biology and structure of CDKs, which will facilitate the rapid discovery and development of a novel, potent, and selective Cdk2 inhibitor. Incyclix Bio was founded by industry experts with robust drug design, discovery, and development experience, including Patrick Roberts, John Bisi, Fredric N. Eshelman, and Jay C. Strum. Patrick Roberts has been the CEO since incorporation. | Pharmaceuticals: Major | Founder Founder | |
ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Investor Relations Contact |
Statistics
International
United States | 43 |
United Kingdom | 7 |
Canada | 2 |
Sectoral
Health Technology | 28 |
Consumer Services | 18 |
Commercial Services | 3 |
Technology Services | 2 |
Operational
Director/Board Member | 64 |
Corporate Officer/Principal | 47 |
Independent Dir/Board Member | 18 |
Undergraduate Degree | 17 |
Chief Executive Officer | 14 |
Most connected contacts
Insiders | |
---|---|
Fred Eshelman | 34 |
Andrew Witty | 24 |
Barclay Phillips | 16 |
Garry Nicholson | 16 |
Alicia Secor | 12 |
Alexander D. Smith | 10 |
Jack Bailey | 9 |
William C. Roberts | 8 |
Shannon Morris | 7 |
Chandra D. Lovejoy | 7 |
Ostra Jewell | 6 |
Jay C. Strum | 6 |
Shannon Morris | 5 |
Mark Avagliano | 5 |
John Demaree | 4 |
- Stock Market
- Insiders
- David D. Elks
- Company connections